A Study to Evaluate the Safety and Tolerability of Long-Acting Oral Risperidone (LYN-005) in Participants With Schizophrenia or Schizoaffective Disorder
PHASE3
Lyndra Therapeutics, Inc., is developing a long-acting oral (LAO) treatment...
A Study to Evaluate the Effect of Oral Paliperidone Extended-Release and Oral Risperidone Immediate-Release on Cognitive Function in Clinically Stable Patients With Schizophrenia
PHASE4
The purpose of this study is to compare the effect of oral paliperidone ext...
Characterization of Intramuscular Injections of Risperidone 4 Week Long-acting Injectable (LAI) Formulation in the Buttock of Patients With Schizophrenia
PHASE1
The purpose of this study is to explore the pharmacokinetics, safety and to...
A Study of Extended Release Extended-release (ER) OROS Paliperidone Tolerability, as Compared to Immediate-release (IR)Risperidone, in Patients With Schizophrenia
PHASE1
The purpose of this study is a noninferiority comparison of the orthostatic...